Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection

Circulation

Volumn 101, Issue 20, 2000, Pages 2405-2410

  Hornick, Philip I ^b   Mason, Philip D ^c   Baker, Richard J ^c   Hernandez Fuentes, Maria ^c   Frasca, Loredana ^c   Lombardi, Giovanna ^c   Taylor, Kenneth ^c   Weng, Ling ^c   Rose, Marlene L ^a   Yacoub, Magdi H ^a   Batchelor, Richard ^c   Lechler, Robert I ^c  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c NONE

Author keywords

Immune system; Immunology; Lymphocytes; Rejection; Transplantation

Indexed keywords

HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TETANUS TOXOID;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034705008     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.20.2405     Document Type: Article

References (33)

1. Lechler R, Batchelor J. Immunogenicity of retransplanted rat kidney allografts. J Exp Med. 1982;156:1835-1841.
2. Lechler R, Batchelor J. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med. 1982;155:31-41.
3. Lechler R, Lombardi G, Batchelor J, Reinsmoen N, Bach F. The molecular basis of alloreactivity. Immunol Today. 1990;11:83-88.
4. Lechler RI, Heaton T, Barber L, Ball V, Batchelor J, Lombardi G. Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses. Immunol Lett. 1992;34:63-70.
5. Batchelor J, Welsh K, Maynard A, Burgos H. Failure of long surviving passively enhanced kidney allografts to provoke T-dependent alloimmunity. J Exp Med. 1979;150:455.
6. Braun M, McCormack A, Webb G, Batchelor J. Mediation of acute but not chronic rejection of the MHC incompatible rat kidney grafts by alloreactive CD4 T cells activated by the direct pathway of sensitisation. Transplantation. 1993;55:177-182.
7. Hornick P, Smith J, Pomerance A, Banner N, Mitchell A, Rose M, Yacoub M. The influence of acute rejection episodes, HLA matching and donor/recipient phenotype on the development of 'early' transplant associated coronary artery disease. Circulation. 1997;96(suppl II):148-153.
8. Hornick P, Lechler R. Direct and indirect pathways of allorecognition: relevance to acute and chronic allograft rejection. Nephrol Dial Transplant. 1997;12:1806-1810.
9. Hornick P, Mason P, Yacoub M, Rose M, Batchelor J, Lechler R. Assessment of the contribution that direct allorecognition makes to the progression of transplant rejection in humans. Circulation. 1998;97: 1257-1263.
10. Mason P, Robinson C, Lechler R. Detection of donor-specific hyporesponsiveness following late failure of human renal allografts. Kidney Int. 1996;50:1019-1025.
11. Frasca L, Amendola A, Hornick P, Uren J, Marelliberg F, Lechler RI, Lombardi G. The role of donor and recipient antigen presenting cells in priming and maintaining T cells with indirect specificity. Transplantation. 1998;66:1238-1243.
12. Matsumura M, Saito Y, Jackson M, Song E, Peterson P. In vitro peptide binding to soluble empty class I major histocompatibility complex molecules isolated from transfected Drosophila melanogaster cells. J Biol Chem. 1992;267:23589-23595.
13. Yamada K, Sachs D, DerSimonian H. Human anti-porcine xenogeneic T cell response: evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J Immunol. 1995;155:5249-5256.
14. Reed E, Hong B, Ho E, Harris P, Weinberger J, Suciu-Foca N. Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease. Transplantation. 1996;61:566-572.
15. Rudensky A, Preston-Hurlbut P, Hong S, Barlow A, Janeway C Jr. Sequence analysis of peptides bound to MHC class II molecules. Nature. 1991;353:622-627.
16. Chicz R, Urban R, Lane W, Gorga S, Stern L, Vignali D, Strominger J. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC relayed molecules and are heterogenous in size. Nature. 1992;358:764-768.
17. Gao A, Alderman E, Schroeder J, Silverman J, Hunt S. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol. 1988;12:334-340.
18. Hornick P, Brookes P, Mason P, Taylor KM, Yacoub M, Rose M, Batchelor J, Lechler R. Optimizing a limiting dilution culture system for quantifying the frequency of IL-2 producing alloreactive helper T lymphocytes. Transplantation. 1997;64:472-479.
19. Gillis S, Smith K. Long term culture of tumor-specific cytotoxic T cells. Nature. 1977;268:154-156.
20. Mosmann T, Yokata T, Kastelein R, Zurawski S, Arai N, Takebe Y. Species specificity of T cell stimulating activities of IL-2 and BSF (IL-4). J Immunol. 1987;138:1813-1816.
21. Finney D. Statistical Method in Biological Assay. London: Charles Griffin; 1978.
22. Liu Z, Coloval A, Tugulea S, Reed E, Fisher P, Mancini D, Rose E, Cortesini R, Michler R, Suciu-Foca N. Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest. 1996;98: 1150-1157.
23. Vella J, Spadafora-Ferreira M, Murphy B, Alexander S, Harmon W, Carpenter C, Sayegh M. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation. 1997;64:795-800.
24. Van Besouw N, Vaessen L, Daane C, Jutte N, Balk A, Claas F, Weimar W. Peripheral monitoring of direct and indirect alloantigen presentation pathways in clinical heart transplant recipients. Transplantation. 1996; 61:165-167.
25. Ross R. The pathogenesis of atherosclerosis, an update. N Engl J Med. 1986;314:488-500.
26. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
27. Braun M, McCormack A, Webb G, Batchelor J. Evidence for clonal anergy as a mechanism responsible for the transplantation tolerance. Eur J Immunol. 1993;23:1462-1468.
28. Boussiotis V, Freeman G, Gray G, Gribben J, Nadler L. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance. J Exp Med. 1993;178:1753-1763.
29. Linsley P, Brady W, Grosmaire L, Aruffo A, Damle N, Ledbetter J. Binding of the B cell activation antigen B7 to CD28 co-stimulates T cell proliferation and interleukin-2 mRNA accumulation. J Exp Med. 1991; 173:721-730.
30. June C, Bluestone J, Nadler L, Thompson C. The B7 and CD28 receptor families. Immunol Today. 1994;15:321-331.
31. Zanker B, Joos-Rudiger J, Franz H, Wagner H, Kabelitz D. Evidence that functional deletion of donor-reactive T lymphocytes in kidney allograft recipients can occur at the level of cytotoxic T cells, IL-2-producing cells or both. Transplantation. 1993;56:628-632.
32. Reinsmoen N, Jackson A, McSherry C, Ninova D, Wiesner R, Krom R, Bolman M, Matas A. Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients. Transplantation. 1995;60: 1546-1554.
33. DeBruyne L, Renlund D, Bishop D. Evidence that human cardiac allograft acceptance is associated with a decrease in donor-reactive helper T lymphocytes. Transplantation. 1995;59:778-783.